Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund and Insider Trading News: Third Point LLC, Paul Singer, Evofem Biosciences Inc (EVFM), Global Eagle Entertainment Inc (ENT), Iterum Therapeutics PLC (ITRM), and More

Worldview Wants to Buy Third Point’s Stake in Hellenic Bank (Bloomberg)
Worldview Capital Management LLP, an activist firm with a history of bruising shareholder battles, says it’s ready to buy a stake in Cyprus’s Hellenic Bank Pcl from billionaire Dan Loeb’s Third Point LLC, as investors stalk the Mediterranean island once again. The firm, which holds less than 5 percent of Hellenic Bank, wants to buy Third Point’s 26 percent stake, according to Worldview founder and partner Angelo Moskov. A Cypriot media report on Thursday said that Loeb’s hedge fund wants to sell its shares to Atlas Merchant Capital LLC, JC Flowers & Co. and Pacific Investment Management Co.

Singer Says Tougher Disclosure Rules Would Threaten Activism (Bloomberg)
Billionaire Paul Singer said efforts to require earlier disclosure for new investments in the U.S. pose a threat to activist investors including his Elliott Management Corp. “It’s already very hard and it’s going to get harder,” Singer said Thursday at The Deal’s Corporate Governance 2018 conference in New York. “There are legislative efforts to reduce the time. But even the existing filing requirements makes it difficult to build a position.”

Insider Trading, NYSE, Markets, Stock Trader On The Phone

Image By Monkey Business – Adobe

Insider Buying: Evofem Biosciences (EVFM) Major Shareholder Acquires 2,127,659 Shares of Stock (TheLincolnianOnline)
Evofem Biosciences Inc (NASDAQ:EVFM) major shareholder Ltd. Invesco acquired 2,127,659 shares of the company’s stock in a transaction that occurred on Tuesday, May 22nd. The shares were acquired at an average cost of $4.69 per share, for a total transaction of $9,978,720.71. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Insider Buying: Global Eagle Entertainment Inc (NASDAQ:ENT) Insider Buys 1,078,594 Shares of Stock (RegistrarJournal.com)
Global Eagle Entertainment Inc (NASDAQ:ENT) insider Tbo-W L.P. Searchlight II bought 1,078,594 shares of the firm’s stock in a transaction on Tuesday, May 22nd. The stock was purchased at an average cost of $1.81 per share, for a total transaction of $1,952,255.14. The purchase was disclosed in a filing with the Securities & Exchange Commission.

Insider Buying: Jason Industries Inc (NASDAQ:JASN) Major Shareholder Acquires $139,236.00 in Stock (StockNewsTimes.com)
Jason Industries Inc (NASDAQ:JASN) major shareholder Wynnefield Partners Small Cap purchased 49,200 shares of Jason Industries stock in a transaction that occurred on Tuesday, May 29th. The shares were bought at an average price of $2.83 per share, with a total value of $139,236.00. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Insider Buying: Iterum Therapeutics PLC (NASDAQ:ITRM) Director Acquires 456,099 Shares of Stock (MaconDaily.com)
Iterum Therapeutics PLC (NASDAQ:ITRM) Director Patrick J. Heron bought 456,099 shares of the firm’s stock in a transaction that occurred on Wednesday, May 30th. The shares were purchased at an average cost of $13.00 per share, with a total value of $5,929,287.00. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website.

Insider Buying: FAT Brands Inc (NASDAQ:FAT) Director Acquires 20,000 Shares of Stock (RegistrarJournal.com)
FAT Brands Inc (NASDAQ:FAT) Director James C. Neuhauser purchased 20,000 shares of the firm’s stock in a transaction dated Wednesday, May 16th. The stock was acquired at an average cost of $6.74 per share, with a total value of $134,800.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Insider Selling: United Cannabis Corp (CNAB) VP Sells 32,298 Shares of Stock (MaconDaily.com)
United Cannabis Corp (OTCMKTS:CNAB) VP Tony Verzura sold 32,298 shares of the company’s stock in a transaction dated Monday, May 21st. The stock was sold at an average price of $1.00, for a total transaction of $32,298.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission.

Insider Selling: American Airlines Group Inc (NASDAQ:AAL) President Sells 10,000 Shares of Stock (StockNewsTimes.com)
American Airlines Group Inc (NASDAQ:AAL) President Robert D. Isom, Jr. sold 10,000 shares of American Airlines Group stock in a transaction on Tuesday, May 22nd. The shares were sold at an average price of $45.00, for a total value of $450,000.00. Following the transaction, the president now owns 646,205 shares of the company’s stock, valued at approximately $29,079,225. The sale was disclosed in a legal filing with the Securities & Exchange Commission.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...